Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects

Detalhes bibliográficos
Autor(a) principal: Costa, AR
Data de Publicação: 2017
Outros Autores: Silva, S, Moura-Ferreira, P, Villaverde-Cabral, M, Santos, O, do Carmo, I, Barros, H, Lunet, N
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10216/111533
Resumo: Background: Cancer screening has contributed to downward trends in cancer mortality, but is also associated with adverse effects, which highlights the importance of promoting the participation based on informed decisions. Objectives: We aimed to describe the use of cancer screening (either in organized programmes or as opportunistic screening), awareness of organized programmes and perception of its potential benefits and adverse effects, depicting possible sex differences. Design and methods: We evaluated 1624 Portuguese-speaking dwellers, aged between 16 and 79 years, through face-to-face interviews. To quantify sex differences, adjusted prevalence ratios and respective 95% confidence intervals were computed using Poisson regression. Results: Among eligible age groups, the lifetime prevalence of screening for breast and cervical cancers was 89.8 and 71.9%, respectively. The prevalence was 23.7% for colorectal cancer and no significant sex differences were observed. Prostate cancer screening was reported by 63.8% of men. Over half of the participants referred that cancers such as prostate, skin, lung and stomach should be screened for, in addition to those for which organized programmes are recommended. Reassurance by negative results was identified as the main potential benefit of screening by nearly one-third of men and women. Anxiety while waiting for results was the most mentioned potential adverse effect (60.4%); men refer less often this and financial costs, although statistical significance of these results was borderline. Conclusions This study provides a benchmark to plan and monitor the effects of awareness-raising interventions, as well as for international comparisons across countries with different cancer prevention and control structures.
id RCAP_f6bc539201894e5d52a23eee40c841a1
oai_identifier_str oai:repositorio-aberto.up.pt:10216/111533
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effectsCancer screening - PortugalBackground: Cancer screening has contributed to downward trends in cancer mortality, but is also associated with adverse effects, which highlights the importance of promoting the participation based on informed decisions. Objectives: We aimed to describe the use of cancer screening (either in organized programmes or as opportunistic screening), awareness of organized programmes and perception of its potential benefits and adverse effects, depicting possible sex differences. Design and methods: We evaluated 1624 Portuguese-speaking dwellers, aged between 16 and 79 years, through face-to-face interviews. To quantify sex differences, adjusted prevalence ratios and respective 95% confidence intervals were computed using Poisson regression. Results: Among eligible age groups, the lifetime prevalence of screening for breast and cervical cancers was 89.8 and 71.9%, respectively. The prevalence was 23.7% for colorectal cancer and no significant sex differences were observed. Prostate cancer screening was reported by 63.8% of men. Over half of the participants referred that cancers such as prostate, skin, lung and stomach should be screened for, in addition to those for which organized programmes are recommended. Reassurance by negative results was identified as the main potential benefit of screening by nearly one-third of men and women. Anxiety while waiting for results was the most mentioned potential adverse effect (60.4%); men refer less often this and financial costs, although statistical significance of these results was borderline. Conclusions This study provides a benchmark to plan and monitor the effects of awareness-raising interventions, as well as for international comparisons across countries with different cancer prevention and control structures.John Wiley & Sons Ltd.20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10216/111533eng1369-6513 10.1111/hex.12450Costa, ARSilva, SMoura-Ferreira, PVillaverde-Cabral, MSantos, Odo Carmo, IBarros, HLunet, Ninfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T14:46:19Zoai:repositorio-aberto.up.pt:10216/111533Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:08:07.939970Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
title Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
spellingShingle Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
Costa, AR
Cancer screening - Portugal
title_short Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
title_full Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
title_fullStr Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
title_full_unstemmed Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
title_sort Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects
author Costa, AR
author_facet Costa, AR
Silva, S
Moura-Ferreira, P
Villaverde-Cabral, M
Santos, O
do Carmo, I
Barros, H
Lunet, N
author_role author
author2 Silva, S
Moura-Ferreira, P
Villaverde-Cabral, M
Santos, O
do Carmo, I
Barros, H
Lunet, N
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Costa, AR
Silva, S
Moura-Ferreira, P
Villaverde-Cabral, M
Santos, O
do Carmo, I
Barros, H
Lunet, N
dc.subject.por.fl_str_mv Cancer screening - Portugal
topic Cancer screening - Portugal
description Background: Cancer screening has contributed to downward trends in cancer mortality, but is also associated with adverse effects, which highlights the importance of promoting the participation based on informed decisions. Objectives: We aimed to describe the use of cancer screening (either in organized programmes or as opportunistic screening), awareness of organized programmes and perception of its potential benefits and adverse effects, depicting possible sex differences. Design and methods: We evaluated 1624 Portuguese-speaking dwellers, aged between 16 and 79 years, through face-to-face interviews. To quantify sex differences, adjusted prevalence ratios and respective 95% confidence intervals were computed using Poisson regression. Results: Among eligible age groups, the lifetime prevalence of screening for breast and cervical cancers was 89.8 and 71.9%, respectively. The prevalence was 23.7% for colorectal cancer and no significant sex differences were observed. Prostate cancer screening was reported by 63.8% of men. Over half of the participants referred that cancers such as prostate, skin, lung and stomach should be screened for, in addition to those for which organized programmes are recommended. Reassurance by negative results was identified as the main potential benefit of screening by nearly one-third of men and women. Anxiety while waiting for results was the most mentioned potential adverse effect (60.4%); men refer less often this and financial costs, although statistical significance of these results was borderline. Conclusions This study provides a benchmark to plan and monitor the effects of awareness-raising interventions, as well as for international comparisons across countries with different cancer prevention and control structures.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10216/111533
url http://hdl.handle.net/10216/111533
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1369-6513 
10.1111/hex.12450
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv John Wiley & Sons Ltd.
publisher.none.fl_str_mv John Wiley & Sons Ltd.
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136006575751169